US9029567B2ActiveUtilityPatentIndex 60
Hypoglycemic compounds
Est. expiryApr 5, 2030(~3.8 yrs left)· nominal 20-yr term from priority
C07D 403/14C07D 487/04A61K 31/4985C07D 401/04C07D 401/14C07D 403/12C07D 209/52C07D 471/04A61P 3/10C07D 473/04A61K 47/65
60
PatentIndex Score
2
Cited by
5
References
8
Claims
Abstract
The present invention relates to novel hypoglycemic compounds of formula (1) and pharmaceutically acceptable salts thereof. The invention relates to novel amino acid derivatives of the formula (1), wherein, A is amino acid B is peptide bond R-NH- wherein R is defined in the specification.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A compound of formula 1,
wherein, A is an amino acid selected from glycine, alanine, β-alanine, valine, histidine, serine, leucine, isoleucine, phenylalanine, methionine, tryptophan, lysine, glutamine, glutamic acid, proline, cysteine, tyrosine, arginine, asparagine, aspartic acid, or threonine;
wherein R-NH- is selected from formulae 2 to 6:
or a pharmaceutically acceptable salt thereof.
2. The compound of claim 1 , wherein R-NH- is formula 2, or a pharmaceutically acceptable salt thereof.
3. The compound of claim 1 , wherein R-NH- is formula 3, or a pharmaceutically acceptable salt thereof.
4. The compound of claim 1 , wherein R-NH- is formula 4, or a pharmaceutically acceptable salt thereof.
5. The compound of claim 1 , wherein R-NH- is formula 5, or a pharmaceutically acceptable salt thereof.
6. The compound of claim 1 , wherein R-NH- is formula 6, or a pharmaceutically acceptable salt thereof.
7. A compound selected from:
or a pharmaceutically acceptable salt thereof.
8. A compound selected from:
or a pharmaceutically acceptable salt thereof.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.